Evolva Holding S.A.
ELVAF
Price:
$1.1
Market Cap:
$5.64M
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bea...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
ELVAF
PE Ratio
[-7.33]
ROE
[-13.27%]
Current Ratio
[8.34]
Dividend Yield
[0%]
Enterprise Value
[-673566.00]
Dividend History
The ROE as of December 2025 (TTM) for Evolva Holding S.A. (ELVAF) is -13.27%
According to Evolva Holding S.A.’s latest financial reports and current stock price. The company's current ROE is -13.27%. This represents a change of -86.13% compared to the average of -95.67% of the last 4 quarters.
Evolva Holding S.A. (ELVAF) Historical ROE (quarterly & annually)
How has ELVAF ROE performed in the past?
The mean historical ROE of Evolva Holding S.A. over the last ten years is -205.41%. The current -13.27% ROE has changed -93.54% with respect to the historical average. Over the past ten years (40 quarters), ELVAF's ROE was at its highest in in the June 2024 quarter at 19.00%. The ROE was at its lowest in in the December 2023 quarter at -388.47%.
Average
-205.41%
Median
-19.12%
Minimum
-1895.13%
Maximum
15.83%
Evolva Holding S.A. (ELVAF) ROE by Quarter and Year
Discovering the peaks and valleys of Evolva Holding S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.54%
Maximum Annual ROE = 15.83%
Minimum Annual Increase = -100.84%
Minimum Annual ROE = -1895.13%
| Year | ROE | Change |
|---|---|---|
| 2024 | 15.83% | -100.84% |
| 2023 | -1895.13% | 4.54% |
| 2022 | -40.82% | 30.34% |
| 2021 | -31.32% | 52.12% |
| 2020 | -20.59% | 64.17% |
| 2019 | -12.54% | -16.66% |
| 2018 | -15.05% | -14.80% |
| 2017 | -17.66% | -15.99% |
| 2016 | -21.02% | 32.88% |
| 2015 | -15.82% | 28.29% |
Evolva Holding S.A. (ELVAF) Average ROE
How has ELVAF ROE performed in the past?
The current ROE of Evolva Holding S.A. (ELVAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-640.04%
5-year avg
-394.41%
10-year avg
-205.41%
Evolva Holding S.A. (ELVAF) ROE vs. Peers
How is ELVAF’s ROE compared to its peers?
Evolva Holding S.A.’s ROE is greater than Finch Therapeutics Group, Inc. (-86.83%), less than Resverlogix Corp. (6.06%), greater than Starpharma Holdings Limited (-47.38%), greater than Bonus BioGroup Ltd. (-824.03%), less than Celyad Oncology S.A. (67.42%), greater than Institute of Biomedical Research Corp. (-79.06%), greater than Voyageur Pharmaceuticals Ltd. (-249.45%), greater than Hadasit Bio-Holdings Ltd (-184.02%), greater than Avicanna Inc. (-53.37%), greater than Positron Corporation (-531.64%),
| Company | ROE | Market cap |
|---|---|---|
| -86.83% | $22.80M | |
| 6.06% | $28.73M | |
| -47.38% | $87.83M | |
| -824.03% | $93.43M | |
| 67.42% | $8.06M | |
| -79.06% | $16.23M | |
| -249.45% | $17.84M | |
| -184.02% | $1.33M | |
| -53.37% | $19.32M | |
| -531.64% | $19.37M |
Build a custom stock screener for Evolva Holding S.A. (ELVAF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evolva Holding S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Evolva Holding S.A. (ELVAF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Evolva Holding S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Evolva Holding S.A.'s ROE?
How is the ROE calculated for Evolva Holding S.A. (ELVAF)?
What is the highest ROE for Evolva Holding S.A. (ELVAF)?
What is the 3-year average ROE for Evolva Holding S.A. (ELVAF)?
What is the 5-year average ROE for Evolva Holding S.A. (ELVAF)?
How does the current ROE for Evolva Holding S.A. (ELVAF) compare to its historical average?